List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #27,881 to #27,930.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. IL-15Interleukin 15
  2. IL-16Interleukin 16
  3. IL-2Interleukin 2
  4. IL-21Interleukin 21
  5. IL-27Interleukin 27
  6. IL-4Interleukin 4
  7. IL-5Interleukin 5
  8. IL-6Interleukin 6
  9. IL-7Interleukin 7
  10. IL-7 receptorInterleukin 7
  11. IL-8Interleukin 8
  12. IL-9Interleukin 9
  13. IL10RBInterleukin 10 receptor, beta subunit
  14. IL11RAInterleukin 11 receptor alpha subunit
  15. IL12RB1Interleukin 12 receptor, beta 1 subunit
  16. IL12RB2Interleukin 12 receptor, beta 2 subunit
  17. IL15RAInterleukin 15 receptor, alpha subunit
  18. IL1R1Interleukin 1 receptor, type I
  19. IL20RAInterleukin 20 receptor, alpha subunit
  20. IL21R geneIL21R
  21. IL5RAInterleukin 5 receptor alpha subunit
  22. IL6RInterleukin-6 receptor
  23. IL8RAInterleukin 8 receptor, alpha
  24. IL9RInterleukin-9 receptor
  25. ILDInterstitial lung disease
  26. ILLUMINATEInvestigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events
  27. ILLUMINATE trialILLUMINATE Trial
  28. ILLUSTRATEInvestigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation
  29. IMAGESIntravenous Magnesium Efficacy In Stroke
  30. IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomesSpecial:Badtitle/NS100:IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes
  31. IMIInnovative Medicines Initiative
  32. IMPACTIntegrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial
  33. IMPACT-HFInitiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
  34. IMPACT IIIntegrilin To Minimise Platelet Aggregation And Coronary Thrombus - II
  35. IMPROVE-CHFImproved Management Of Patients With Congestive Heart Failure
  36. IMPROVEDDIMPROVEDD VTE risk score
  37. IMPROVEDD risk scoreIMPROVEDD risk score calculator
  38. IMPROVEDD risk score calculatorIMPROVEDD VTE risk score
  39. IMPROVEDD scoreIMPROVEDD VTE risk score
  40. IMPROVED scoreIMPROVEDD risk score calculator
  41. IMPROVE Score CalculatorIMPROVE risk score calculator
  42. IMPROVE and IMPROVEDIMPROVE and IMPROVEDD scores for venous thromboembolism
  43. IMPROVE associative score for VTEIMPROVE score for venous thromboembolism#IMPROVE Associative Score for VTE
  44. IMPROVE predictive score for VTEIMPROVE score for venous thromboembolism#IMPROVE Predictive Score for VTE
  45. IMPROVE risk scoreIMPROVE score
  46. IMPROVE risk score calculatorIMPROVE VTE risk score
  47. IMPROVE risk score for VTEIMPROVE score for venous thromboembolism
  48. IMPROVE risk score for bleedingIMPROVE bleeding risk score
  49. IMPROVE risk score for venous thromboembolismIMPROVE score for venous thromboembolism
  50. IMPROVE scoreIMPROVE VTE risk score

View ( | ) (20 | 50 | 100 | 250 | 500)